<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01597921</url>
  </required_header>
  <id_info>
    <org_study_id>23267384</org_study_id>
    <nct_id>NCT01597921</nct_id>
  </id_info>
  <brief_title>A DB Randomized Study of R1 and R2 WaterJel / AloeVera Jell in Prevention of Radiation Dermatitis in Breast Cancer</brief_title>
  <official_title>Phase II, Double Blinded, Randomized Study of R1 and R2 (Waterjel) Verses Aloe Vera Jell for the Prevention and Treatment of Radiation Induced Dermatitis in Breast Cancer Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Water-Jel</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Water-Jel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effects of topical R1 and R2 for prophylaxis of
      acute radiation dermatitis in patients with breast cancer receiving radiotherapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All women will be given two types of Jell. One should be applied immediately after radiation
      and the second one, 3 times every day. All women will complete detailed questionnaire every
      two weeks and will be evaluated by the treating team at the same time.All women will be
      evaluated two weeks after end of radiation period.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The study was stopped due to unbalanced side effects
  </why_stopped>
  <start_date>May 2012</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">50</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Radiation Dermatitis</condition>
  <condition>Erythema</condition>
  <arm_group>
    <arm_group_label>Breast cancer patient receiving RT</arm_group_label>
    <description>Total dose:2Gy/Fx</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        75
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Woman with histologically confirmed breast cancer who underwent lumpectomy and
             requires adjuvant radiation therapy with 2 Gy/fx to a total dose of 50 Gy.

          2. Women who received neoadjuvant or adjuvant chemotherapy are eligible for the study.
             Three weeks is the minimal interval between chemotherapy and start of radiation
             therapy.

          3. Patient able to understand the study designed and cooperate with instructions of use.

          4. Patient able to sign informed consent

        Exclusion Criteria:

          1. Woman with lactose allergy (lactose intolerance are eligible)

          2. Woman with known connective tissue disorder

          3. Woman with uncontrolled diabetes

          4. Patients receiving radiation protocol with 2.64 Gy/fx or 1.8 Gy/fx

          5. Woman who is unable to sign an informed consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Merav Ben David</last_name>
    <role>Principal Investigator</role>
    <affiliation>La Sheba Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Ramat-Gan</city>
        <zip>55555</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 10, 2012</study_first_submitted>
  <study_first_submitted_qc>May 11, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 14, 2012</study_first_posted>
  <last_update_submitted>August 8, 2012</last_update_submitted>
  <last_update_submitted_qc>August 8, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 9, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Water-Jel</investigator_affiliation>
    <investigator_full_name>Dr Merav Ben-David</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>Breast conserving surgery</keyword>
  <keyword>Radiation dermatitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Erythema</mesh_term>
    <mesh_term>Radiodermatitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

